Your browser doesn't support javascript.
loading
Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL.
Nix, Matthew A; Mandal, Kamal; Geng, Huimin; Paranjape, Neha; Lin, Yu-Hsiu T; Rivera, Jose M; Marcoulis, Makeba; White, Kristie L; Whitman, Jeffrey D; Bapat, Sagar P; Parker, Kevin R; Ramirez, Jonathan; Deucher, Anne; Phojanokong, Paul; Steri, Veronica; Fattahi, Faranak; Hann, Byron C; Satpathy, Ansuman T; Manglik, Aashish; Stieglitz, Elliot; Wiita, Arun P.
  • Nix MA; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Mandal K; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Geng H; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Paranjape N; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Lin YT; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Rivera JM; Department of Pediatrics, University of California, San Francisco, San Francisco, California.
  • Marcoulis M; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • White KL; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Whitman JD; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Bapat SP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Parker KR; Department of Pathology, Stanford University, Stanford, California.
  • Ramirez J; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California.
  • Deucher A; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
  • Phojanokong P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Steri V; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Fattahi F; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California.
  • Hann BC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Satpathy AT; Department of Pathology, Stanford University, Stanford, California.
  • Manglik A; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California.
  • Stieglitz E; Department of Anesthesia, University of California, San Francisco, San Francisco, California.
  • Wiita AP; Department of Pediatrics, University of California, San Francisco, San Francisco, California.
Cancer Discov ; 11(8): 2032-2049, 2021 08.
Article en En | MEDLINE | ID: mdl-33727310
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Antígenos de Diferenciación de Linfocitos B / Antígenos CD / Antígenos CD19 / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Antígenos de Diferenciación de Linfocitos B / Antígenos CD / Antígenos CD19 / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article